2:00 PM - 2:45 PM
On Trend: Better Strategies for Complex and Rare Disease Management
FDA approvals for specialty drugs are at an all-time high. Specialty spend—especially on the medical benefit—continues to soar. Small patient populations with complex and rare diseases are driving that trend. What strategies are emerging to better manage cost of care while working to improve patient outcomes? In this session we will examine current utilization, spend, and comprehensive management trends for hemophilia, rare diseases, and more.